Alprostadil alfadex - Schwarz Pharma

Drug Profile

Alprostadil alfadex - Schwarz Pharma

Alternative Names: Alprostadil alfadex complex - Schwarz Pharma; Alprostadil-alpha-cyclodextrin; Edex; Prostaglandin E1-α-cyclodextrin complex; Prostandin; Prostavasin; Rigidur®; Sugiran; Vasaprostan; Vasoprost; Viridal

Latest Information Update: 16 Mar 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ono Pharmaceutical
  • Developer Ono Pharmaceutical; UCB
  • Class Alpha-Cyclodextrins; Erectile dysfunction therapies; Peripheral vasodilators; Prostaglandins
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Erectile dysfunction; Peripheral arterial disorders

Most Recent Events

  • 16 Mar 2015 Launched for Erectile dysfunction (Diagnosis) in Japan (Intracavernous) before March 2015
  • 16 Mar 2015 Launched for Peripheral arterial disorders in Russia, South Korea and China (Intra-arterial) before March 2015
  • 29 Apr 2013 Actient Pharmaceuticals has been acquired by Auxilium Pharmaceuticals
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top